Mamedica

Company Overview

• Mamedica was founded by Jon Robson in 2021.
• Raised £1 million from private investors.
• Obtained licenses from the Care Quality Commission and General Pharmaceutical Council.
• Reported a 400% increase in patients since inception.

Patient Conditions and Treatment Focus

• 40% of prescriptions for mental health conditions.
• Increased demand from patients with psychiatric conditions opting for medical cannabis.
• Prescribes CBD for menopause symptoms like hot flushes.
• Supports patients with chronic neurological pain using cannabis-based prescription medicines (CBPMs).
• Aims to improve quality of life by reducing symptoms of depression and anxiety.
• Doctors can prescribe THC, CBD, and balanced cannabis profiles.
• Prescriptions include cannabis flower, oil, capsules, and cartridges.
• Cannabis flower strictly for use in dry-herb vaporizers.
• Focus on providing relief for patients with chronic conditions and improving overall quality of life.

Patient Eligibility and Legislation

• Over 89,000 private medical cannabis prescriptions in the UK compared to fewer than five via the NHS.
• UK legislation requires prescription initiation by a specialist consultant.
• Patients must have tried two licensed medications before consulting Mamedica.
• No history of schizophrenia or psychosis allowed.
• Medical records and family medical history details are mandatory.

Patient Perception and Market Growth

• Published a survey in August 2022 revealing 60% of Britons open to using cannabis for medical purposes.
• More than half of Brits unaware they can access cannabis on prescription.
• Third of Brits would opt for medical cannabis to treat mental health conditions.
• England to become the second largest medical cannabis market in Europe.

References

• Leigh, Dana (December 5, 2022). A Chat with Jon Robson, CEO at Mamedica.
• Waugh, Rob (15 August 2022). Most British people would now consider using medical cannabis, survey shows.
• Roberts, Joe (4 August 2023). More than half of Brits unaware they can access cannabis on prescription.
• Maule, Will (26 February 2023). Third of Brits would opt for medical cannabis to treat mental health conditions.
• Shehadi, Sebastian (April 17, 2023). England to become the second largest medical cannabis market in Europe.

Mamedica Data Sources